Clinical Trials – Society of Cannabis Clinicians https://www.cannabisclinicians.org Educating Healthcare Professionals about the Medical Use of Cannabis Sat, 03 Jun 2023 19:24:00 +0000 en-US hourly 1 https://wordpress.org/?v=6.2.3 https://www.cannabisclinicians.org/wp-content/uploads/2020/07/cropped-scc-flavicon-32x32.png Clinical Trials – Society of Cannabis Clinicians https://www.cannabisclinicians.org 32 32 Cannabinoids in Treating Parkinson’s Disease Symptoms: A Systematic Review of Clinical Studies https://www.cannabisclinicians.org/2023/06/03/cannabinoids-in-treating-parkinsons-disease-symptoms-a-systematic-review-of-clinical-studies/ Sat, 03 Jun 2023 19:24:00 +0000 https://www.cannabisclinicians.org/?p=28745 Parkinson’s disease (PD) is a serious neurodegenerative condition impacting many individuals worldwide. There is a need for new non-invasive treatments of PD. Cannabinoids in the form of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) may offer utility as treatment, and our objective was hence to conduct a systematic review regarding the clinical evidence for the efficacy and safety of cannabinoids in treating PD.

The post Cannabinoids in Treating Parkinson’s Disease Symptoms: A Systematic Review of Clinical Studies appeared first on Society of Cannabis Clinicians.

]]> Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment https://www.cannabisclinicians.org/2022/12/22/therapeutic-effects-of-cannabinoids-and-their-applications-in-covid-19-treatment/ Thu, 22 Dec 2022 16:59:40 +0000 https://www.cannabisclinicians.org/?p=27347 Cannabidiol is showing promising results for the treatment of COVID-19, due to its capa- bility of acting on the unleashed cytokine storm, on the proteins necessary for both virus entry and replication and on the neurological consequences of patients who have been infected by the virus. Here, we summarize the latest knowledge regarding the advantages of using cannabinoids in the treatment of COVID-19.

The post Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment appeared first on Society of Cannabis Clinicians.

]]> A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma https://www.cannabisclinicians.org/2016/08/11/a-safety-study-of-sativex-in-combination-with-dose-intense-temozolomide-in-patients-with-recurrent-glioblastoma/ Thu, 11 Aug 2016 18:39:42 +0000 https://www.cannabisclinicians.org/?p=14818 Authors: Susan Short, Christopher Twelves, Lucy Brazil, Catherine McBain, et al
Clinicaltrials.gov, 11 August 2016
---
An open-label phase to assess the frequency and severity of adverse events in recurrent glioblastoma patients receiving Sativex in combination with dose-intense Temozolomide (Part A). A randomisation phase to assess the safety of Sativex compared with placebo (Part B). Patient...

The post A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma appeared first on Society of Cannabis Clinicians.

]]>